S2533 Efficacy and Safety of Atezolizumab Plus Bevacizumab Compared to Tyrosine Kinase Inhibitors (Sorafenib and Lenvatinib) as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Year: 2025
Type: conference-abstract
Authors: Rishikesh R. Magaji, Vinay Chandramouli Bellur, Omar Oudit, Trisha Chandra Mohan, Ananya Prasad, Vibhav MS, Shradha Chervittara Karaveetil, Deepak Bhat, Keerthi Balaji Babu Naidu, Pavan Kumara Kasam Shiva, Vardhini Ganesh Iyer, Aditya Singh, Allama Prabhu N S, Adithya Sathya Narayana
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417239154
Cites:
Cited by:
Related to: